Human immunodeficiency virus (HIV) is a retrovirus that causes acquired immunodeficiency syndrome (AIDS, a condition in humans in which the immune system begins to fail, leading to life-threatening opportunistic infections).
Huge decline in HIV rates in Zimbabwe driven by fear of infection, says study – The big drop in the numbers of people infected with HIV in Zimbabwe is because of mass social change, driven by fear of infection, according to an international study reported in the journal PLoS Medicine.
Expansion of HIV screening cost-effective in reducing spread of AIDS, Stanford study shows – An expanded U.S. program of HIV screening and treatment could prevent as many as 212,000 new infections over the next 20 years and prove to be very cost-effective, according to a new study by Stanford University School of Medicine researchers.
HIV virus hides in the brain – Studies of the spinal fluid of patients given anti-HIV drugs have resulted in new findings suggesting that the brain can act as a hiding place for the HIV virus.
Exciting new avenues of research and policy drive expansion of HIV treatment access, use of antiretrovirals to prevent infections and pursuit of a cure — Exciting new avenues of research and policy – The unwillingness of the global AIDS community to accept the status quo is fuelling a new era of scientific innovation to drive novel ways of treating and preventing HIV, organizers of the XVIII International AIDS Conference (AIDS 2010) taking place in Vienna, Austria said today.
Fellowships for outstanding research in drug use and HIV are presented by the International AIDS Society and the National Institute on Drug Abuse at AIDS 2010 – The International AIDS Society (IAS) and the National Institute on Drug Abuse (NIDA) today announced the recipients of their second annual joint research fellowships. Recipients of the prestigious awards will receive US$75,000 each to advance the scientific understanding of the linkage between illicit drug use and HIV, while fostering multinational research.
NIH-led scientists find antibodies that prevent most HIV strains from infecting human cells — Discovery to advance HIV vaccine design, antibody therapy for other diseases – Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory, and have demonstrated how one of these disease-fighting proteins accomplishes this feat.
Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women — New research presented at International Microbicides Conference – A new study finds that pregnancy is a time when men are at greater risk. In fact, their risk doubles if their partner is both HIV-infected and pregnant.
Discovery of how BanLec binds to key HIV-1 protein opens door to developing microcides that can prevent sexual transmission of HIV
– A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a University of Michigan Medical School study published this week.
UCSF study finds clinic-based HIV prevention is effective in reducing risk behaviors – Delivering HIV prevention services to people living with HIV in clinical settings can sharply reduce their sexual risk behaviors, revealed by UCSF researchers.
University of Michigan scientists discover bone marrow can harbor HIV-infected cells — Targeting these reservoirs of latent cells may open door to new treatments – University of Michigan scientists have identified a new reservoir for hidden HIV-infected cells that can serve as a factory for new infections. This indicate a new target for curing the disease so those infected with the virus may someday no longer rely on AIDS drugs for a lifetime.
